OpenSAFELY Vaccine Coverage Report

AstraZeneca / Priority Group 1

Data from combined, up to 2021-03-20.

Vaccinated at 2021-03-20 (%) Vaccinated at 2021-03-20 (n) Population Vaccinated at 2021-03-13 (%) Vaccinated in past week (%)
Overall - 66.6% 201,187 302,092 66.0% 0.6%
Sex Female 66.9% 128,317 191,842 66.4% 0.4%
Male 66.1% 72,870 110,250 65.3% 0.8%
Ethnicity White - British 67.2% 129,087 192,220 66.6% 0.6%
White - Irish 68.2% 1,708 2,506 67.9% 0.3%
White - Any other White background 58.3% 3,675 6,300 57.7% 0.7%
Mixed - White and Black Caribbean 60.5% 364 602 58.1% 2.3%
Mixed - White and Black African 50.0% 126 252 47.2% 2.8%
Mixed - White and Asian 61.8% 147 238 58.8% 2.9%
Mixed - Any other mixed background 63.2% 301 476 60.3% 2.9%
Asian or Asian British - Indian 64.0% 1,330 2,079 63.0% 1.0%
Asian or Asian British - Pakistani 56.3% 497 882 54.8% 1.6%
Asian or Asian British - Bangladeshi 59.3% 245 413 59.3% 0.0%
Asian or Asian British - Any other Asian background 58.8% 700 1,190 57.6% 1.2%
Black or Black British - Caribbean 58.7% 1,344 2,289 57.5% 1.2%
Black or Black British - African 51.2% 721 1,407 49.3% 2.0%
Black or Black British - Any other Black background 58.3% 441 756 56.5% 1.9%
Other ethnic groups - Chinese 58.0% 203 350 58.0% 0.0%
Other ethnic groups - Any other ethnic group 59.9% 700 1,169 59.3% 0.6%
Patients with any other ethnicity code 68.0% 26,537 39,004 67.5% 0.6%
Ethnicity not stated 65.1% 1,785 2,744 64.8% 0.3%
Ethnicity not recorded 66.2% 31,171 47,089 65.8% 0.4%
Ethnicity (broad categories) White 66.9% 134,491 201,040 66.3% 0.6%
Mixed 59.5% 945 1,589 57.7% 1.8%
South Asian 61.0% 2,793 4,578 59.8% 1.2%
Black 56.4% 2,520 4,466 54.9% 1.6%
Other 59.2% 903 1,526 58.7% 0.5%
Unknown 67.0% 59,507 88,851 66.5% 0.5%
Index of Multiple Deprivation 1 (most deprived) 64.4% 39,256 60,921 63.8% 0.7%
2 68.7% 43,358 63,070 68.0% 0.8%
3 68.0% 43,218 63,567 67.4% 0.6%
4 66.7% 40,418 60,571 66.2% 0.5%
5 (least deprived) 64.9% 33,796 52,087 64.5% 0.4%
Unknown 60.8% 1,120 1,841 60.1% 0.8%
Clinical Risk Groups Patients in Any Clinical Risk Group 67.6% 176,386 260,827 67.1% 0.6%
Patients with Immunosuppression 65.7% 6,062 9,233 65.1% 0.5%
Patients with CKD 66.5% 50,225 75,523 66.2% 0.3%
Patients who have Chronic Respiratory Disease 66.1% 18,480 27,965 65.7% 0.4%
Patients with Diabetes 66.9% 38,199 57,120 66.4% 0.5%
Patients with Chronic Liver disease 65.9% 5,215 7,917 64.9% 1.0%
Patients with CNS Disease (including Stroke/TIA) 68.7% 105,399 153,412 68.2% 0.5%
Patients with Chronic heart disease 66.7% 72,632 108,871 66.4% 0.4%
Patients with Asplenia or Dysfunction of the Spleen 67.1% 1,554 2,317 66.8% 0.3%
Patients with Wider Learning Disability 75.2% 34,118 45,395 73.9% 1.3%
Patients with Severe Mental Health 66.5% 20,055 30,177 65.5% 1.0%
Other Groups Patients who are shielding (High Risk from COVID-19) 67.9% 143,759 211,855 67.5% 0.3%
Patients with Morbid Obesity 67.1% 5,488 8,176 65.8% 1.3%
Patients who are pregnant 23.8% 35 147 23.8% 0.0%